Alltrna
MA - CambridgeBiotechnology
Focus: Alltrna is a biotechnology company focused on developing tRNA therapies, a novel modality within gene therapy based in Cambridge, MA. Founded in 2014 and now public, the company represents an emerging player in precision genetic medicine.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Total Funding
$6B
Open Jobs
1+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Alltrna?
AI assessmentAlltrna is a speculative early-stage bet on an unproven modality best suited for scientists and operators comfortable with high technical risk and limited near-term career advancement pace.
Why Work Here
- Pioneering tRNA therapeutic modality offers exposure to cutting-edge gene therapy innovation with significant differentiation from competitors
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Interview Prep Quick Facts
Help build intelligence for Alltrna
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.